Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124913572 | 12491357 | 2 | F | 20130525 | 20160802 | 20160623 | 20160816 | EXP | US-ACCORD-041586 | ACCORD | 45.00 | YR | F | Y | 102.06000 | KG | 20160816 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124913572 | 12491357 | 1 | PS | Glimepiride Accord | GLIMEPIRIDE | 1 | STRENGTH: 4 MG?ALSO RECEIVED 4 MG 2 TABLETS DAILY 30 DAYS STARTING 05-APR-2016 | U | 78181 | 4 | MG | TABLET | BID | ||||||
| 124913572 | 12491357 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | ALSO RECEIVED 850 MG 1 TABLETS THREE TIMES DAILY 30 DAYS STARTING 05-APR-2016 | U | 0 | 850 | MG | BID | |||||||
| 124913572 | 12491357 | 3 | SS | LYRICA | PREGABALIN | 1 | CURRENTLY 200 MG, THREE TIMES DAILY | U | L91498 | 0 | |||||||||
| 124913572 | 12491357 | 4 | SS | SEPTRA | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | U | 0 | |||||||||||
| 124913572 | 12491357 | 5 | C | OXYCODONE/OXYCODONE HYDROCHLORIDE/OXYCODONE PECTINATE/OXYCODONE TEREPHTHALATE | 2 | 6 TABLETS DAILY?ALSO RECEIVED 10 MG EVERY FOUR HOUR 30 DAYS STARTING 10-MAY-2016. | 0 | 10 | MG | TABLET | Q4H | ||||||||
| 124913572 | 12491357 | 6 | C | NOVOLIN | INSULIN HUMAN | 1 | ALSO RECEIVED (N 100 UNIT/ML) 40 UNITS THREE TIMES DAILY AC, 30 DAYS STARTING 10-MAY-2016. | 0 | TID | ||||||||||
| 124913572 | 12491357 | 7 | C | CYCLOBENZAPRINE/CYCLOBENZAPRINE HYDROCHLORIDE | 2 | 10 MG BY MOUTH AS NEEDED | 0 | 10 | MG | ||||||||||
| 124913572 | 12491357 | 8 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 50 MG BY MOUTH EVERY NIGHT?ALSO 50 MG ONE TABLETS AT EVERY NIGHT DAILY 30 DAYS STARTING 05-APR-2016 | 0 | 50 | MG | |||||||||
| 124913572 | 12491357 | 9 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 25 MG TABLET AS NEEDED?ALSO RECEIVED 25 MG 1 TABLETS DAILY 30 DAYS STARTING 07-JUN-2016 | 0 | 25 | MG | TABLET | ||||||||
| 124913572 | 12491357 | 10 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | 0 | 5 | MG | TABLET | TID | ||||||||
| 124913572 | 12491357 | 11 | C | CITALOPRAM/CITALOPRAM HYDROBROMIDE/CITALOPRAM HYDROCHLORIDE | 2 | 0 | 20 | MG | TABLET | BID | |||||||||
| 124913572 | 12491357 | 12 | C | Relion insulin syringe | 2 | 31GX5/16 DEGREE 0.5 ML?ONE SYRINGE TWO TIMES DAILY, 100 SYRINGE 50 DAYS STARTING 05-MAR-2016. | 0 | ||||||||||||
| 124913572 | 12491357 | 13 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 108 (90 BASE) MCG/ACT | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124913572 | 12491357 | 1 | Type 2 diabetes mellitus |
| 124913572 | 12491357 | 2 | Type 2 diabetes mellitus |
| 124913572 | 12491357 | 3 | Diabetic neuropathy |
| 124913572 | 12491357 | 4 | Product used for unknown indication |
| 124913572 | 12491357 | 5 | Pain |
| 124913572 | 12491357 | 6 | Type 2 diabetes mellitus |
| 124913572 | 12491357 | 7 | Muscle relaxant therapy |
| 124913572 | 12491357 | 8 | Somnolence |
| 124913572 | 12491357 | 9 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124913572 | 12491357 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124913572 | 12491357 | Amnesia | |
| 124913572 | 12491357 | Drug ineffective | |
| 124913572 | 12491357 | Hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |